BBA
VERV
Baker Bros. Advisors’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19M | Hold |
1,691,530
| – | – | 0.18% | 39 |
|
|
2025
Q1 | $7.73M | Hold |
1,691,530
| – | – | 0.09% | 50 |
|
|
2024
Q4 | $9.54M | Hold |
1,691,530
| – | – | 0.1% | 54 |
|
|
2024
Q3 | $8.19M | Hold |
1,691,530
| – | – | 0.08% | 59 |
|
|
2024
Q2 | $8.25M | Hold |
1,691,530
| – | – | 0.11% | 54 |
|
|
2024
Q1 | $22.5M | Hold |
1,691,530
| – | – | 0.28% | 39 |
|
|
2023
Q4 | $23.6M | Buy |
1,691,530
+275,000
| +19% | +$3.83M | 0.27% | 36 |
|
|
2023
Q3 | $18.8M | Hold |
1,416,530
| – | – | 0.11% | 38 |
|
|
2023
Q2 | $26.6M | Hold |
1,416,530
| – | – | 0.15% | 37 |
|
|
2023
Q1 | $20.4M | Hold |
1,416,530
| – | – | 0.11% | 37 |
|
|
2022
Q4 | $27.4M | Hold |
1,416,530
| – | – | 0.16% | 32 |
|
|
2022
Q3 | $48.7M | Hold |
1,416,530
| – | – | 0.32% | 28 |
|
|
2022
Q2 | $21.6M | Hold |
1,416,530
| – | – | 0.12% | 47 |
|
|
2022
Q1 | $32.3M | Hold |
1,416,530
| – | – | 0.19% | 42 |
|
|
2021
Q4 | $52.2M | Hold |
1,416,530
| – | – | 0.25% | 35 |
|
|
2021
Q3 | $66.6M | Hold |
1,416,530
| – | – | 0.29% | 28 |
|
|
2021
Q2 | $85.3M | Buy |
+1,416,530
| New | +$85.3M | 0.37% | 24 |
|